RANDOMIZED PHASE II TRIAL OF CONCURRENT CHEMORADIOTHERAPY +/- METFORMIN HCL IN LOCALLY ADVANCED NSCLC (NRG-LU001)

Sponsor: NRG Oncology

Protocol number: NRG-LU001

Projected enrollment dates: December 2014 to December 2017

Official study title: RANDOMIZED PHASE II TRIAL OF CONCURRENT CHEMORADIOTHERAPY +/- METFORMIN HCL IN LOCALLY ADVANCED NSCLC (NRG-LU001)